Skip to main content
Clinical Trials/TCTR20221024003
TCTR20221024003
Enrolling By Invitation
Not Applicable

The difference of infant's gut microbiome between cesarean delivery and vaginal delivery

Strategic Wisdom and Research Institute, Srinakharinwirot University0 sites280 target enrollmentOctober 24, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infant gut microbiome
Sponsor
Strategic Wisdom and Research Institute, Srinakharinwirot University
Enrollment
280
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 24, 2022
End Date
December 31, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Strategic Wisdom and Research Institute, Srinakharinwirot University

Eligibility Criteria

Inclusion Criteria

  • 1\. Term healthy newborn with normal vital signs and physical examination. 2\. Delivered at HRH Maha Chakri Sirindhorn Medical Center, Faculty of Medicine, Srinakharinwirot University, Thaialnd. 3\. Delivered from pregnant women with no infection history. 4\. Delivered from pregnant women not received antibiotic treatment except for Cesarean empirical antibiotic prophylaxis.

Exclusion Criteria

  • 1\. Infant's fecal specimen cannot be corrected within 48 hours after delivery
  • 2\. Infant diagnosed with gastrointestinal abnormalities, other structural abnormalities or genetic disease after delivery.
  • 3\. Infant diagnosed with complications after delivery e.g., jaundice that need phototherapy or exchanged transfusion, early neonatal sepsis
  • 4\. Infant received antibiotic within 48\-72 hours after delivery before collecting the fecal specimen.

Outcomes

Primary Outcomes

Not specified

Similar Trials